Challenges facing the pharmaceutical industry in the 21st century -- The cellular basis of cardiac electrophysiology -- Clinical arrhythmia syndromes -- The mechanisms underlying cardiac arrhythmias -- The mechanisms underlying drug-induced arrhythmias -- Assessing cardiac safety in drug development -- Pediatric cardiac safety -- Drug-induced atrial fibrillation -- Navigating the future path of cardiac drug safety.